chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient admitted on 11/5 for increased BP and noted to have an AKI on his CKD as well as urinary retention. Creatinine trended down appropriate during the admission and is now very near his baseline. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
patient got Covid after their first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (patient got Covid after their first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 11J20A0) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (patient got Covid after their first dose). At the time of the report, COVID-19 (patient got Covid after their first dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. They were instructed to wait 90 days until Covid resolved. The patient had now surpassed the 90 days.
our fridge being out of range on 12/02/22 for one hour; No adverse event; 10 patients vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (10 patients vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened), PRODUCT STORAGE ERROR (our fridge being out of range on 12/02/22 for one hour) and NO ADVERSE EVENT (No adverse event) in an 11-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 02-Dec-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (10 patients vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (our fridge being out of range on 12/02/22 for one hour) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (10 patients vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened), PRODUCT STORAGE ERROR (our fridge being out of range on 12/02/22 for one hour) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (10 patients vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened) and PRODUCT STORAGE ERROR (our fridge being out of range on 12/02/22 for one hour).    No concomitant medicine were reported. HCP stated 10 patients from 6 months to 5 years were vaccinated with monovalent Moderna COVID-19 Vaccine after an excursion happened. One patient was vaccinated on 09Dec2022 and 9 patients were vaccinated on 16Dec2022. Excursion happened on 02Dec2022 during 1 hour and minimum temperature reached was 1.2°C. No treatment medicine were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jan-2023: Live Follow-up received and contains event 'Product temperature excursion issue'
This spontaneous report has been received from a medical assistant, referring to a patient of unknown age and gender. It was reported that the patient was administered an expired dose of PNEUMOVAX 23 (lot # K020215, expiration date 15-MAY-2016) on 19-MAY-2016. No adverse effect reported. Additional information has been requested.
First few days after vaccination had sore arm and headache. By the 4th day the headaches had substantially increased into full-blown migraines. Extreme, debilitating fatigue. Body aches that kept me from sleeping. Pain on right side of head behind ear that felt like I had been hit. Could not do normal housework. April 1 I went to the emergency room where they gave me IV Toradol which alleviated the pain for 2 or 3 days. April 21 I got in to see my PCP. She prescribed a Medrol Dose Pack. Today is my last day of that.
96 hours after shot- nausea, vomiting, diarrhea, fever (highest 102.0F)
On 9/22/10 pt had (R) leg pain & could not walk to the bathroom & had enuresis. He had decreased po's, low grade temp. Pt unable to walk 9/22 pt began to walk with limp 9/23PM. 9/22 MD eval & work up for septic initiated.
The bandaid fell off the next evening and he has a rectangular bruise at the injection site the shape of the bandaid. He only noticed it Saturday evening, so we don't know when the bruise formed.
14year old patient brought in for Pfizer Vaccine dose #2. patient was given Pfizer pediatric vaccine (5-12) in error. Mother was present and informed of administration error. Provider also informed and CDC recommendations reviewed: do not repeat dose.
the patient was administered an improperly stored dose of VAQTA; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concomitant therapies, drug allergies and concurrent condition were not provided.  On 22-MAY-2020, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) (lot # S020241, expiration date 23-AUG-2020; dose detail, strength and route were not provided) for prophylaxis (product storage error). The temperature excursion included 12.1 Celsius degree for 16 hours and 11 minutes. There was no preciously temperature excursion. There was a data logger involved. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S020241; expirationdate: 23-AUG-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
No additional AEs.; a TE for ROTATEQ, product administered after the excursion.; This spontaneous report was received from a medical assistant and referred to a patient of unknown age or gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reaction/allergies were not reported.   On 05-APR-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dosage form, lot #W026136, expiration date: 31-JAN-2024, administered orally for prophylaxis (strength was not provided), after the temperature excursion (product storage error). Suspect vaccine experienced the temperature excursion of 61.7 degree Fahrenheit for 4 hours 39 minutes. There was no previous temperature excursion. No additional adverse event.
11:38  PSO298% pulse 113 reports throat feels tight and pain down his left arm to his elbow.  11:42  pain down left arm to wrist at this time. At vaccine site arm is blotchy red.  Throat is feeling better.    11:52 left arm vaccine sight it itching at this time. Throat tightening is almost not noticeable. Ready to leave.  PSO2 99% pulse 91.  Informed to seek medical attention for further problems and to report the issue for today.
patients arm started to swell right away after given injection, applied ice, swelling started to decrease, after about a minute patient complained of feeling lightheaded and felt he was going to pass out/never did stayed seated entire time, then a few minutes after that patient had cold sweats, called 911, stayed with patient entire time until rescue arrived. no tightness in chest or breathing issues, patient started to feel a little better when they arrived, took them about 10 minutes to arrive. patient did go with rescue to hospital to be checked.
Pt recv vax on 9/15/98; 8 hrs later pt exp fever (99.3), splotches on right shoulder, stomach &back; pt was "spaced out".  Pt mom advised to call w/ any more rxs.
So me and my spouse started feeling sick in December. Feeling really tired, loss of appetite, congestion, and feverish. The congestion felt like it was getting worse, and forcing ourselves to eat and drink since we weren't hungry. On the 20th of December I had a doctor's routine appointment where I told her the symptoms and we were tested for COVID and tested positive. We kept taking over the counter medication and it gradually diminished in the course of 4 weeks, the cough being the last to go. I did not need to use the inhaler during this time which was really good.
HCP reporting VAQTA, PEDVAXHIB, and ROTATEQ were administered after a temperature excursion. Caller stated she did not have the exact dates of administration nor the names of the patients involved. No additional information provided. No additional AE; No additional AE reported; This spontaneous report was received from a  Health Care Professional and refers to a 2-year-old female. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 12-DEC-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, in right thigh, lot #W023937, expiration date: 06-DEC-2023, administered intramuscularly for prophylaxis (strength was not provided).  The administered dose of the vaccine experienced a temperature excursion (product storage error) since 01-DEC-2022. The vaccine administered were stored at temperatures excursion of 47.9 Fahrenheit (storage in clinical practice) for 47 minutes . Digital data logger was involved.  No adverse event was reported.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2301USA009024:
Information has been received from a medical assistant referring to a patient of unknown age and gender. Concurrent condition and medical history of the patient was not reported. On 12-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # reported as L003188, expiration date: 06-JUL-2016) (dose and route unspecified). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
possible blood clotting; burning sensation on her left side particulary her foot and leg same side she got shot in her arm; her toes on left are still a little tingly; This is a spontaneous report from a contactable consumer. This consumer reported for a female other HCP (patient)  that the female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration, administered in arm on an unspecified date in Jul2021 as dose 1, single for covid-19 immunisation. Medical history included history of not responding well to vaccine shots including the flu shot which gave her shingles. No medical conditions beside history of intolerance to vaccines.The patient's concomitant medications were not reported. Patient was a nurse at a dermatology office and she knew who got COVID vaccine in July. She directly reported it to field force (consumer) as both reporter and patient. She experienced a burning sensation on her left side particularly her foot and leg same side she got shot in her arm. She said that her primary care doc was worried about possible blood clotting so advised against her 2nd shot. She said that her toes on left were still a little tingly so she was concerned to take second shot which she was supposed to take on an unspecified date. The outcome of event her toes on left were still a little tingly was not recovered while the outcome of other events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient received 3rd dose of Pfizer vaccine instead of  Moderna (patient's previous 2 COVID-19 vaccine doses were Moderna). This discovery was made when patient came back with card to get vaccination recorded as he did not have it at the time of vaccination. Patient did not report any adverse effects and had no reaction during his recommended 15 minute waiting period before leaving to get his card. Patient was made aware of the situation and told to contact PCP if any adverse effects arise.
Pt was underage by 6 months when he received the first dose because parent put the incorrect DOB on consent form. Doctor was notified and he said if pt is ok after first dose that he may finish the second dose.
I have not been feeling well; The vaccination site is still sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from agency. The reporter is the patient.  A 78-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "I have not been feeling well"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "The vaccination site is still sore".  Additional information: Patient received a Prevnar 20 vaccination on 06Oct. The vaccination site was still sore. She was not feeling well. She wanted to know that other side effects have lasted this long.  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 23-AUG-2013 the patient was vaccinated with VARIVAX (Merck) (lot # G007814 and exp date reported on 16-AUG-2013) 0.5 ml, subcutaneous. No other co suspects were reported. No concomitant therapy was reported. The nurse reported that the patient received an expired dose of VARIVAX (Merck). No adverse event reported. Additional information has been requested.
Vaccination 1/22/08; Reaction started 2/9/08 Erythema multiforme on 2/6/08. Rx with orapred.
My symptoms started on Wednesday of last week which was January 25. I had a dry cough, but I already have asthma and COPD. I requested albuterol thru a nebulizer treatment the night before. I had a progressively increasing sore throat and earache throughout the day. My blood pressure was high but better than it had been. I had just had my corticosteroids tapered from the medical dose back to the home dose. I do believe this weakened my immune system at that point. My voice had changed. By the next few hours, I was at the demonic toad way speaking. That night I had diarrhea, severe nausea, cold sweats and my temperature was at 99. I also had muscle aches. The next morning, I was coughing up clear solids from my lungs and throat. I had minor nasal congestion that required a change in oxygen mask. My urine became more concentrated and cloudier. My fever progressed to 102 with both hot and cold sweats and minor fever delirium. My lungs progressed to colored both yellow and brown. After doing my lung exercise, a chest x-ray was performed. I was not given the results. I was tested via blood and lung mucus for bacterial. My fever broke on Sunday morning and I was discharged to home and home health care. I was sent home. I did an intake with 2 nurses from home health. I am still symptomatic. I am still disoriented, have diarrhea, migraine joint and muscle pain, blurry vision. I'm on a prophylactic antibiotic called Levo Lexine.
COVID vaccine breakthrough case  dose 1 Pfizer  1/26/21  EL9261 dose 2 Pfizer  2/25/21  EN6202 dose 3 Pfizer 10/3/21  FF2587
More frequent flares of the herpetic rash on her buttock.  It flared twice after the second vaccine shot.  She had a similar rash under the right axilla after her first shot (which was given 2/24/21).  A similar rash on the left leg after the second shot and after the two episodes involving the buttock.  A fourth rash then began at a different site on the right buttock, more laterally.  The rashes respond to Valtrex.
pt recv vax & devel swelling all over & a rash;pt also felt cold & dizzy;
Started feeling a salty after taste on my mouth; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 10Mar2021 at 07:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and migraine headaches. The patient had allergy to benzonatate. Concomitant medication included amlodipine (MANUFACTURER UNKNOWN) 5 milligram (mg). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19. On 13Mar2021 at 09:00, the patient experienced salty taste in her mouth. It was reported that the week after the vaccine, the patient was fine. Everything she ate would taste as if she sprinkled salt on the top. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. On 14Mar2021, the patient had nasal swab test and the result was negative. The clinical outcome of taste salty was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
My son die the next day after receiving his vaccines.  I gave him .8ml of tylenol about 4:45pm and he had a bottle an hour earlier. It was time for his nap because he was crying but never thought he wouldn't wakeup again. My oldest son (18) pick him up and found that he wasn't breathing and blue he called 911.  He was rushed to hospital.  This was about 7:30 pm. Follow up report received 04/07/2005:  On the day following vaccination, child had loose stool in AM and was more fussy than usual.  When son found him not breathing, he was lying on the chest of his 12 year old sister with his face turned toward the back of the sofa and his nose pressed against the sofa. Received medical records from PCP & ER. Autopsy Report received which revealed COD as SIDS while cosleeping.  Therapeutic level of pseudoephedrine (0.87 mg/L) was found on autopsy.
I had not had a period in over two years, I began spotting which turned into heavy bleeding with golf ball size blood clots. This lasted for 8 weeks. I was seen by my OBGYN which then began a series of tests including a DNC, there was no know cause found.
Rotateq vaccine inappropriately administered at 40 weeks of age.  100.4 fever reporter by mom the day after vaccine administration.
None stated 11/9/07-records received for DOS 10/20-10/23/07- DC DX: Fever resolved. Possible adverse reaction to immunization resolved. Leukocytosis, resolved. Bilateral otitis medica resolving. Admitted with high grade fever 104, 48 hours after administration of vaccines. Erythema and swelling at injection site.
dizziness; She's had chills; stomachache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 09:40 (Batch/Lot number: unknown) at the age of 34 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "gall bladder removed", start date: Nov2020 (not ongoing), notes: Verbatim: last November they removed her gallbladder. Concomitant medication(s) included: VITAMIN D [VITAMIN D NOS]. The following information was reported: DIZZINESS (non-serious) with onset 06May2021, outcome "recovering", described as "dizziness"; CHILLS (non-serious) with onset 06May2021, outcome "recovering", described as "She's had chills"; ABDOMINAL PAIN UPPER (non-serious) with onset 06May2021, outcome "recovering", described as "stomachache".  Additional information: patient received the first dose of Pfizer's covid vaccine on Saturday, 01may2021 (6 days ago). She had chills, a stomachache, and dizziness and they started last night and are still going on but probably getting better. Patient wondering if these symptoms are normal and is it normal to have them this far out and asking if she should get the second dose. It was reported concomitant products she takes vitamin d as a vitamin. She has taken for approximately four weeks. No investigation assessment. Patient does not see lot, ndc, or expiration on her vaccine record card. She received the vaccine around 9:40 am. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No vaccines administered on same date with the Pfizer vaccine considered as suspect. Patient had not visited emergency room or physician office, did called her physician. No treatment was reported. Any patient had not taken other vaccinations within four weeks prior to the first administration date of the suspect vaccine. No aes following prior vaccinations. Family medical history relevant to aes was reported none that she knows of.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Became sick after 6 hours; Vomited uncontrollably with a fever for 12 hours; Vomited uncontrollably with a fever for 12 hours; This is a spontaneous report from a non-contactable reporter (consumer or other non HCP). The reporter is the patient.   A 37-year-old female patient received bnt162b2 (BNT162B2), administered in left arm, administration date 13Jan2022 at 10:30 (Lot number: FL3198) at the age of 37 years as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: 3013BA, Anatomical location: Left arm, Administration time: 13:00), administration date: 21Dec2021, when the patient was 37 years old, for COVID-19 immunisation.  The following information was reported: ILLNESS (non-serious) with onset 13Jan2022 at 16:30, outcome "recovering", described as "Became sick after 6 hours"; VOMITING (non-serious), PYREXIA (non-serious) all with onset 13Jan2022 at 16:30, outcome "recovering", and all described as "Vomited uncontrollably with a fever for 12 hours". Therapeutic measures were not taken as a result of illness, vomiting and pyrexia.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Contracted COVID  19 on  9/2/2021 -tested positive on 9/3/2021 Mild symptoms: low grade fever, head ache, stuffy nose, slight cough, loss of taste and smell Treated with monoclonal antibody transfusion 9/7/2021 Tested negative on 9/14/2021